This technology uses the pTCY plasmid to carry the antigen gene, and combines with peptide nanotubes to make a nanocarrier vaccine. The advantages include high surface area, long residence time, low toxicity, etc. It is the best delivery system for antigens and drugs. We used software to analyze the structural proteins with the best antigenicity of pathogens and constructed effective gene fragments into expressed DNA plasmids. This technology platform can be applied to various mucosal diseases.
Administration with recombinant fragment of human SP-D (rfhSP-D) in t he diagnosis and treatment for chronic obstructive pulmonary disease
Development of HEK293 cell culture process for Coxsackievirus vaccine pr oduction
Development of Key Components for Intelligent 5-Axis Machine Tools
Development of novel cannabinoid CB1receptor antagonists with high oral absorption and no central adverse effects for the treatment of cardiovascular diseases
Technology maturity：Experiment stage
Exhibiting purpose：Display of scientific results
Trading preferences：Negotiate by self
Coming soon!